| |
| |
|
| Insider
Information: |
Shandell Jason B. |
| Relationship: |
President and General ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
179,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,171,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,276 |
|
|
| Total
Value |
$7,171,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
President and General ... |
2020-03-17 |
179,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2014-09-26 |
4 |
D |
$11.83 |
$9,109 |
D/D |
(770) |
120,897 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-03-26 |
4 |
D |
$11.96 |
$56,379 |
D/D |
(4,714) |
233,526 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-03-27 |
4 |
D |
$11.96 |
$71,018 |
D/D |
(5,938) |
227,588 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-03-16 |
4 |
D |
$13.03 |
$102,846 |
D/D |
(7,893) |
124,109 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-17 |
4 |
D |
$13.75 |
$96,924 |
D/D |
(7,049) |
259,822 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-26 |
4 |
D |
$13.76 |
$64,865 |
D/D |
(4,714) |
255,108 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-03-15 |
4 |
D |
$14.19 |
$97,854 |
D/D |
(6,896) |
132,002 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-27 |
4 |
D |
$14.27 |
$84,735 |
D/D |
(5,938) |
249,170 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-05 |
4 |
OE |
$14.40 |
$224,856 |
D/D |
15,615 |
154,513 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-06 |
4 |
OE |
$14.40 |
$315,835 |
D/D |
21,933 |
160,831 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-07 |
4 |
OE |
$14.40 |
$98,683 |
D/D |
6,853 |
145,751 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-03-17 |
4 |
D |
$14.50 |
$134,836 |
D/D |
(9,299) |
179,276 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-02-14 |
4 |
OE |
$15.23 |
$114,514 |
D/D |
7,519 |
175,837 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2015-03-27 |
4 |
D |
$15.43 |
$90,960 |
D/D |
(5,895) |
164,181 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-05-25 |
4 |
AS |
$15.60 |
$16,754 |
D/D |
(1,074) |
226,514 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-07-05 |
4 |
D |
$16.33 |
$55,424 |
D/D |
(3,394) |
214,584 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-06-09 |
4 |
AS |
$16.43 |
$162,723 |
D/D |
(9,904) |
216,610 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-30 |
4 |
S |
$16.76 |
$131,230 |
D/D |
(7,828) |
241,342 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-07-11 |
4 |
AS |
$16.77 |
$241,422 |
D/D |
(14,399) |
199,505 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2015-07-05 |
4 |
D |
$17.24 |
$58,513 |
D/D |
(3,394) |
160,787 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-31 |
4 |
S |
$17.26 |
$63,070 |
D/D |
(3,654) |
237,688 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-07-05 |
4 |
D |
$17.95 |
$60,922 |
D/D |
(3,394) |
235,493 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-08-11 |
4 |
AS |
$18.01 |
$101,482 |
D/D |
(5,636) |
208,948 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-01-08 |
4 |
AS |
$18.44 |
$460,978 |
D/D |
(25,000) |
138,898 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-27 |
4 |
D |
$18.47 |
$144,676 |
D/D |
(7,833) |
212,561 |
0 |
- |
|
85 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
